Heart Attack Clinical Trial
Official title:
Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition Improves Left Ventricular Function and Reduces Adverse Left-Ventricular Remodeling in High-Risk Patients With Microvascular Obstruction (MVO) Following ST-elevation Myocardial Infarction (STEMI).
The purpose of the research is to determine whether a medication called dapagliflozin will improve the heart's function and reduce its enlargement after a heart attack. Participation in this study will involve taking the medication dapagliflozin (or a placebo) once daily for six months, one cardiac magnetic resonance imaging (MRI) test during your initial hospitalization, follow-up phone calls at 1 and 3 months, and one cardiac MRI and clinic visit at six months.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
| Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
| Completed |
NCT01467232 -
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
|
Phase 2 | |
| Completed |
NCT05090618 -
The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population
|
||
| Active, not recruiting |
NCT03561051 -
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
|
||
| Enrolling by invitation |
NCT04664881 -
Home Telemonitoring In Patients After Myocardial Infarction
|
N/A | |
| Completed |
NCT03826914 -
The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults
|
N/A | |
| Withdrawn |
NCT04198883 -
SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand)
|
Phase 1/Phase 2 | |
| Completed |
NCT03649711 -
Chronic Kidney Disease (CKD) Platelet Study
|
Phase 3 | |
| Completed |
NCT03677180 -
National Cardiogenic Shock Initiative
|
||
| Active, not recruiting |
NCT05415735 -
Stress Management and Resiliency Training Following Acute Myocardial Infarction
|
N/A | |
| Completed |
NCT02376283 -
P3AMI Antiplatelet Trial
|
Phase 4 | |
| Completed |
NCT03654157 -
ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow
|
||
| Not yet recruiting |
NCT05720156 -
Immunomodulatory Effects of PCSK9 Inhibition
|
||
| Completed |
NCT03252990 -
18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
|
||
| Recruiting |
NCT06271577 -
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
|
N/A | |
| Recruiting |
NCT06280976 -
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
|
Phase 4 | |
| Completed |
NCT02581540 -
Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin
|
||
| Recruiting |
NCT04904107 -
Improving the Accuracy of Referrals of Patients With Chest Pain
|
N/A | |
| Completed |
NCT02032030 -
Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
|